With a team of seasoned professionals, including epidemiologists, statisticians, medical experts, data scientists, and project managers, SIGMA brings a wealth of expertise, competence and experience to every project. SIGMA experts are at the forefront of pharmacoepidemiologic research – by being active investigators and shaping industry standards through authoring guidelines – ensuring that study funders benefit from the latest scientific advancements and best practices.
We leverage cutting-edge technology and methodologies to provide innovative solutions tailored to the unique needs of each research question. From robust causal inference framework designs, advanced data analytics to state-of-the-art modelling techniques, SIGMA is equipped to tackle complex public health and clinical safety issues with precision and creativity.
At SIGMA, we believe that collaboration is key to success. We work closely with our clients, European partners, and other stakeholders to maintain a collaborative environment that encourages the exchange of ideas and the development of comprehensive strategies. Our consortium is committed to building strong, lasting relationships that drive positive outcomes.
Quality is at the core of everything we do at SIGMA. SIGMA Members adhere to rigorous standards and protocols to ensure the highest level of accuracy and reliability in our work. Our commitment to quality is reflected in our meticulous attention to detail and our dedication to delivering outstanding and robust results, accompanied by expert scientific interpretation.
SIGMA is proud to contribute to global public health initiatives that make a difference in communities around the world. We are specialized in the conduct of international regulator-mandated studies, whose results are part of risk management plans, which shape medical interventions labeling, their utilization, and guidelines in Europe and globally.
